Literature DB >> 15117900

Suppression of the high endogenous levels of plasma FSH in infertile men are associated with improved Sertoli cell function as reflected by elevated levels of plasma inhibin B.

C Foresta1, A Bettella, D Spolaore, M Merico, M Rossato, A Ferlin.   

Abstract

BACKGROUND: In vitro continuous stimulation of Sertoli cells with FSH leads to a desensitization of these cells to FSH action. To evaluate the presence of a desensitization of FSH receptor on Sertoli cells in vivo, we performed a controlled clinical study in 97 men affected by severe oligozoospermia.
METHODS: On the basis of FSH and inhibin B plasma concentrations, these subjects were divided into three groups: group A, 33 subjects with high FSH and low inhibin B plasma levels; group B, 32 subjects with high FSH plasma levels and inhibin B concentrations at the lower limit of the normal range; and group C, 32 subjects with normal FSH and inhibin B plasma levels. Patients with high FSH plasma levels (groups A and B) were prospectively randomized into two subgroups, called A1, A2, B1 and B2. Patients of groups A1 and B1 were treated with a GnRH agonist, leuprolide acetate, to induce a hypogonadotrophic state and then were treated with recombinant human FSH (r-hFSH; 100 IU/day) and hCG (2000 IU/twice a week) for 2 months. Subjects of groups A2, B2 and C were treated only with r-hFSH for the same period.
RESULTS: In patients of group A1, inhibin B remained unmodified during the whole period of study, whereas in subjects of group B1, we observed a significant reduction of this hormone during the hypogonadotrophic period and then an increase of inhibin B plasma levels that were higher that those observed before therapy. In patients of groups A2 and B2, FSH treatment did not induce a significant increase in inhibin B concentrations. In patients of group C, FSH induced a significant increase in inhibin B plasma levels.
CONCLUSIONS: In infertile men, suppression of the high endogenous levels of plasma FSH associated with much lower exogenous FSH levels is able to evoke higher inhibin B production, which may indicate improved Sertoli cell function and the possibility that this could have a positive effect on spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117900     DOI: 10.1093/humrep/deh255

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Follicle-stimulating hormone enhances recovery from low-dose doxorubicin-induced spermatogenic disorders in mice.

Authors:  Jun Hagiuda; Hiromichi Ishikawa; Satoru Kaneko; Masako Okazaki; Mototsugu Oya; Ken Nakagawa
Journal:  J Assist Reprod Genet       Date:  2015-04-16       Impact factor: 3.412

Review 2.  Hormonal therapy for non-obstructive azoospermia: basic and clinical perspectives.

Authors:  Koji Shiraishi
Journal:  Reprod Med Biol       Date:  2014-09-18

3.  Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients - A proof of concept study.

Authors:  Rita Jakubcionyte Laursen; Birgit Alsbjerg; Helle Olesen Elbaek; Betina Boel Povlsen; Kirsten Brock Spanggaard Jensen; Jette Lykkegaard; Sandro C Esteves; Peter Humaidan
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

Review 4.  Clinical management of infertile men with nonobstructive azoospermia.

Authors:  Sandro C Esteves
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

5.  Does hormonal therapy improve sperm retrieval rates in men with non-obstructive azoospermia: a systematic review and meta-analysis.

Authors:  Tharu Tharakan; Giovanni Corona; Daniel Foran; Andrea Salonia; Nikolaos Sofikitis; Aleksander Giwercman; Csilla Krausz; Tet Yap; Channa N Jayasena; Suks Minhas
Journal:  Hum Reprod Update       Date:  2022-08-25       Impact factor: 17.179

6.  Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review.

Authors:  J Bao; Z Guo; J He; T Leng; Z Wei; C Wang; F Chen
Journal:  Prog Urol       Date:  2022-09-13       Impact factor: 1.090

Review 7.  Medical management of non-obstructive azoospermia.

Authors:  Rajeev Kumar
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

8.  Spermatogenesis improved by suppressing the high level of endogenous gonadotropins in idiopathic non-obstructive azoospermia: a case control pilot study.

Authors:  Xuechun Hu; Zheng Ding; Zhiwei Hong; Zhichuan Zou; Yuming Feng; Ruilou Zhu; Jinzhao Ma; Xie Ge; Chaojun Li; Bing Yao
Journal:  Reprod Biol Endocrinol       Date:  2018-09-22       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.